Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2024 Nov 20;18(11):e0012616. doi: 10.1371/journal.pntd.0012616

Understanding the factors contributing to dengue virus and chikungunya virus seropositivity and seroconversion among children in Kenya

Amna Tariq 1,*,#, Aslam Khan 1,*,#, Francis Mutuku 2, Bryson Ndenga 3, Donal Bisanzio 4, Elysse N Grossi-Soyster 1, Zainab Jembe 5, Priscilla Maina 5, Philip Chebii 5, Charles Ronga 3, Victoria Okuta 3, Angelle Desiree LaBeaud 1
Editor: Chaturaka Rodrigo6
PMCID: PMC11578454  PMID: 39565798

Abstract

Dengue virus (DENV) and chikungunya virus (CHIKV) are causes of endemic febrile disease among Kenyan children. The exposure risk to these infections is highly multifactorial and linked to environmental factors and human behavior. We investigated relationships between household, socio-economic, demographic, and behavioral risk factors for DENV and CHIKV seropositivity and seroconversion in four settlements in Kenya. We prospectively followed a pediatric cohort of 3,445 children between 2014–2018. We utilized the Kaplan–Meier curves to describe the temporal patterns of seroconversion among tested participants. We employed logistic regression built using generalized linear mixed models, to identify potential exposure risk factors for DENV and CHIKV seroconversion and seropositivity.

Overall, 5.2% children were seropositive for DENV, of which 59% seroconverted during the study period. The seroprevalence for CHIKV was 9.2%, of which 54% seroconverted. The fraction of seroconversions per year in the study cohort was <2% for both viruses. Multivariable analysis indicated that older age and the presence of water containers ((OR: 1.15 [95% CI: 1.10, 1.21]), (OR: 1.50 [95% CI: 1.07, 2.10])) increased the odds of DENV seropositivity, whereas higher wealth (OR: 0.83 [95% CI: 0.73, 0.96]) decreased the odds of DENV seropositivity. Multivariable analysis for CHIKV seropositivity showed older age and the presence of trash in the housing compound to be associated with increased odds of CHIKV seropositivity ((OR: 1.11[95% CI: 1.07, 1.15]), (OR: 1.34 [95% CI: 1.04, 1.73])), while higher wealth decreased the odds of CHIKV seropositivity (OR: 0.74[95% CI: 0.66, 0.83]). A higher wealth index (OR: 0.82 [95% CI: 0.69, 0.97]) decreased the odds of DENV seroconversion, whereas a higher age (OR: 1.08 [95% CI: 1.02, 1.15]) and the presence of water containers in the household (OR: 1.91[95% CI: 1.24, 2.95]) were significantly associated with increased odds of DENV seroconversion. Higher wealth was associated with decreased odds for CHIKV seroconversion (OR: 0.75 [95% CI: 0.66, 0.89]), whereas presence of water containers in the house (OR: 1.57 [95% CI: 1.11, 2.21]) was a risk factor for CHIKV seroconversion.

Our study links ongoing CHIKV and DENV exposure to decreased wealth and clean water access, underscoring the need to combat inequity and poverty and further enhance ongoing surveillance for arboviruses in Kenya to decrease disease transmission. The study emphasizes the co-circulation of DENV and CHIKV and calls for strengthening the targeted control strategies of mosquito borne diseases in Kenya including vector control, environmental management, public education, community engagement and personal protection.

Author summary

Dengue virus (DENV) and chikungunya virus (CHIKV) are important arboviral infections that cause endemic febrile disease specially among children in Kenya. Since there is no active surveillance for DENV and CHIKV infections in Kenya, the actual burden of these infections and their associated risk factors remains unknown. In this longitudinal cohort study spanning over a period of five years between 2014–2018, we investigate relationships between household, socio-economic, demographic, and behavioral risk factors for DENV and CHIKV seropositivity and seroconversion in four settlements in Kenya and describe the temporal patterns of seroconversion among the tested participants. The study emphasizes the existence of active DENV and CHIKV disease transmission in Kenya. The results also highlight older age, presence of water containers and trash on the housing compounds to increase the odds of DENV and CHIKV seropositivity and seroconversion whereas a higher wealth index decreased the odds of DENV and CHIKV seropositivity and seroconversion. The results of our study link ongoing CHIKV and DENV exposure in Kenya to lower income and resources, underscoring the need to combat inequity and poverty and enhance ongoing surveillance for arboviruses in Kenya.

Introduction

Chikungunya virus (CHIKV) and dengue virus (DENV) are both mosquito-borne viruses of global importance that have caused widespread morbidity and are endemic in sub-Saharan Africa [1]. They can cause asymptomatic infection or clinical disease presenting as fever with rash, debilitating arthralgias, hemorrhagic fever, leaky capillary syndrome, and in some instances, mortality. This variability in presentation creates a diagnostic challenge for clinicians evaluating individuals with undifferentiated fever, especially in regions where malaria and other infectious diseases present similarly. CHIKV and DENV are both endemic to Kenya with the occurrence of CHIKV first described in the region in 1953 whereas DENV was reported in Zanzibar in the 1800s [2,3]. Since the 1950s, there has been a three-fold increase in urban population density across Africa and, subsequently, multiple outbreaks of DENV and CHIKV have been reported in the region, linking higher population density to the DENV and CHIKV outbreaks [24]. These viruses have an important role in presentations of fever to the medical setting in Kenya, especially with limited diagnostic testing available to differentiate the viruses, underestimating the burden and magnitude of these infections.

DENV and CHIKV are transmitted worldwide by both Aedes aegypti (high competent vector with a higher capacity to transmit virus) and Aedes albopictus (low competent vector with a lower capacity to transmit virus) species. Our previous studies have demonstrated a high burden of Aedes aegypti mosquitoes and their associated risks in western and coastal Kenya [5,6]. Aedes aegypti exhibit a diurnal feeding pattern in contrast to the primarily nocturnal malaria vector, Anopheles spp. mosquitoes. Despite the great burden of DENV and CHIKV and changing epidemiology of these viruses in the region, not much is known about the true burden of DENV and CHIKV infection among the children. In Kenya, given the limited available resources, vector control strategies and surveillance are primarily focused on malaria, undermining the true burden of arboviruses. Additionally, severe hemorrhagic symptoms of dengue, as witnessed in other parts of the world, is rare in Kenya, suggesting less severe disease in sub-Saharan Africa [7]. While some data exists about the notable DENV and CHIKV transmission in Kenya, the magnitude remains mostly unknown [8]. In these circumstances understanding the risk factors associated with DENV and CHIKV seropositivity and seroconversion can assist the health care workers and policy makers towards targeted DENV and CHIKV preventive and control measures [9]. Seroprevalence provides information on past exposure to DENV or CHIKV and seroconversion between two time points demonstrates whether community members have been exposed and infected with DENV or CHIKV within the demonstrated time frame, suggesting active viral transmission in the community.

Although detecting symptomatic clinical cases of DENV and CHIKV can help estimate the prevalence of DENV and CHIKV infections, serological surveys in the general population also include asymptomatic infections. This provides insights into the circulation of the virus and occurrence of new infections as assessed by seroconversions in the cohort, which help to increase awareness of DENV and CHIKV, particularly in the pediatric age group. The high burden of febrile illness in Kenya and persistent DENV and CHIKV transmission merits an assessment of the epidemiological dynamics of DENV and CHIKV infection in Kenya. In this prospective study, we followed a longitudinal pediatric cohort in Kenya to quantify the seroprevalence and seroconversion of DENV and CHIKV and identify the associated risk factors to better understand the continued DENV and CHIKV transmission in Kenya. We also examined the temporal patterns of DENV and CHIKV seroconversion over time in our pediatric cohort.

Methods

In this prospective study, we recruited and followed a cohort of 3,445 children (aged 1–17 years) from January 2014-December 2018 in Kenya to measure DENV and CHIKV seroprevalence and seroconversion over five years. For the purpose of this study, seroprevalence was defined as the percentage of population who had DENV or CHIKV antibodies in their blood indicating that they had been exposed to DENV or CHIKV respectively. Whereas seroconversion was defined as the time-period when a study participant’s DENV or CHIKV antibody test result changed from negative to positive. This study enrolled participants at four distinct sites in proximity to our collaborating institutions, with two sites in coastal Kenya (Ukunda [-4.289796°, 39.567371°] and Msambweni [-4.464405°, 39.471955°]) and two in western Kenya (Kisumu [-0.091702°, 34.767957°] and Chulaimbo [-0.035266°, 34.636908°]). Ukunda and Kisumu are two densely populated “urban” regions whereas the adjacent sites, Msambweni and Chulaimbo are less densely populated sites, representing “peri-urban” or “rural” environments (Fig 1 shows the map of Kenya depicting the study sites created in ArcGIS using the modern antique map as the basemap; https://www.arcgis.com/home/item.html?id=effe3475f05a4d608e66fd6eeb2113c0). The study sites were selected to represent the respective study communities. Study inclusion criteria included (i) age less than 18 years old; (ii) not febrile at the time of enrollment; (iii) agreement to be followed up at 6-month intervals. The exclusion criteria for the study were (i) age less than 1 year; (ii) age 18 years or older; (iii) or residing outside the respective selected study zones. For understanding DENV and CHIKV seroconversion among the study participants, any participant who was DENV or CHIKV seropositive (DENV or CHIKV IgG+) at the beginning of the study (baseline) was excluded from the DENV and CHIKV seroconversion analysis respectively.

Fig 1. Map of Kenya showing the location of our study sites created in ArcGIS using the modern antique map as the basemap; https://www.arcgis.com/home/item.html?id=effe3475f05a4d608e66fd6eeb2113c0.

Fig 1

The child participants were followed over five years with six-month interval blood collection for enzyme-linked immunosorbent assay (ELISA) serologic testing (DENV and CHIKV immunoglobulin G (IgG)) at follow-up visits [1012]. The ELISA IgG testing was conducted at our field research laboratory sites (Msambweni District Hospital and Kenya Medical Research Institute-Kisian) with repeat confirmatory testing performed at Stanford University. Plaque-reduction neutralization test (PRNT)-confirmed serum samples were used to determine the cut-off values on ELISA testing for identification of seropositive and seronegative results for CHIKV and DENV, as previously published [10,12]. A positive result was defined as any sample that had an optical density above three times the value of the negative control and at least half of the positive control reading. In case samples had significant discrepancies between results at both sites, the result for repeat testing at Stanford University was then used for this study [13]. All participants were administered demographic surveys at each six-month follow-up that gathered data on each participant’s age, gender, residence, past-history of infection, recent symptoms, travel, preventive measures for mosquito exposure, and household information. The surveys were answered by the accompanying household member. Participants were enrolled during the first two visits during the 5-year study period and could drop out anytime, with some participants undergoing fewer follow-up visits. We observed dropouts in the cohort over time, however, all visits were scheduled and completed at regular intervals approximately every six months, regardless of the participant presenting with symptoms or not.

Ethical considerations

This study was approved by the Stanford (31488) and Kenya Medical Research Institute, KEMRI (SSC95 2611) institutional review boards. The purpose of the study was explained to all participants and written informed consent/assent was obtained from the parents/guardians of the study participants. Verbal assent was obtained by children seven years or older. Participation in the study was voluntary. All the data and samples were analyzed without name, ID card number, or other directly recognizable types of information.

Statistical analysis

Differences in seropositivity and seroconversion by each study site and across each year were calculated by Chi-square test and a p-value <0.05 was considered to be statistically significant. Univariable logistic regression was used to identify risk factors for seropositivity and seroconversion. Odds ratios and their 95% confidence intervals (95% CI) were calculated. Factors associated (p< 0.05) with seropositivity and seroconversion in univariable analyses were selected for the multivariable analyses. In the final multivariable random effects analyses, we tested statistically significant (p< 0.05) predictors from the univariable models. For each of the predictors included in the univariable and multivariable analysis, the most complete responses were recorded at the baseline. For each of the follow up visits, the surveys focused on interval risk factors for exposure and there were limited responses for most of the predictors included in the univariable and multivariable analyses. Therefore, for any given predictor, if the study participant answered a “yes” in response to that predictor over any of the visits or at the baseline, the response was recorded as a “yes” for the purpose of the analysis. Upon looking into the response heterogeneity over time, a marked difference was not observed in the population across five years.

To evaluate socioeconomic status (SES), a wealth index was calculated for each participant using a Principal Component Analysis (PCA) based on a group weighted mean scores on a range of household items and variables [14]. The items used in the estimation of the wealth index included the ownership of house and its characteristics, access to utilities and infrastructure, presence of livestock, and ownership of durable assets such as a radio, TV, car, bicycle, or telephone (Table A in S1 Text). The correlation between each of the predictors used to construct the wealth index was also checked. These household items were used as a proxy for income to calculate the ordinal wealth index, as all four study sites belong to lower income strata. A descriptive analysis of the different household items and variables was carried out to determine their frequency and standard deviation. A co-variance matrix was generated for the PCA as all the variables were standardized to the same unit (binary yes = 1/no = 0). These results were used to create an ordinal wealth score that placed each participant into quartiles of rising wealth that stratified households based on their wealth index score, with quartile 1 indicating lowest wealth index and quartile 4 indicating the highest wealth index for the household, depending on the presence of household items in the house. A household crowding index was calculated for each household and was defined as the total number of co-residents living in the household divided by the number of rooms in the house. The crowding index score of 1–2 was defined as low crowding whereas the index of 3 or more was considered to be high crowding. No information on the size of the rooms was available to calculate the room density. A mosquito index was created and designated positive if the participants used either a mosquito coil, mosquito repellent or mosquito spray to avoid mosquito bites during the study. The presence of any uncovered water vessels, including water buckets, water barrels, and water tires around the house were included in the analysis as a “water container” as these water vessels can serve as potential mosquito breeding sites by collecting water for longer periods of time. The wealth index, mosquito index, and crowding index did not change over time.

Logistic regression fitting generalized linear mixed models (GLMMs) with random effect, binomial error structure and a logit link function was applied to assess the risk factors associated with DENV and CHIKV IgG antibody seroprevalence and seroconversion [15]. GLMMs are an extension of generalized linear models that include both fixed and random effects. The random slope allows the fixed effect to vary for each subject.

All demographic factors (such as age group, gender, living on the coast, village, urban or rural setting), number of people living in household, wealth index, presence of water containers in house (including water buckets, water barrels and water tires), child travel (defined as a child traveling for more than 10 km away from his home in the last 6 months), outdoor time (answered as a “yes” or “no” to the question if a child usually spends time outdoors for work or any activities), presence of trash in the living compound, use of window screens, use of any kind of mosquito control (mosquito coil, spray, and repellent), and sleeping under mosquito nets were included in the univariable logistic regression analysis for both DENV and CHIKV seroprevalence and seroconversion. To account for repeated sampling (more than one individual) from the same household, a multivariable GLMM was then fitted to analyze the risk factors associated with DENV and CHIKV seroprevalence and seroconversion using living on the coast or west as the random effect. Significance of association was determined through the adjusted odds ratio (OR) estimates with 95% confidence intervals (95%CI) and p<0.05. Model selection technique based on Akaike Information Criterion (AIC) was used to identify those variables providing the best logistic regression model [16].

To describe the temporal patterns of DENV and CHIKV seroconversion, the survival person-days of follow-up time were calculated as the time between the date of the first visit and (i) the visit when seroconversion was identified, and (ii) the last date of participation in the study, incorporating right-censoring. Kaplan Meier curves were fitted to observe the progression of individuals in the study and when individuals seroconvert for DENV and CHIKV and log rank test was used to compare survival curves across the four villages, coast and west as well as the urban (more densely populated) and rural (less densely populated) sites. All statistical analyses used in this study were performed with the R language (Version 2022.12.0+35) [17].

Results

Characteristics of study population

During the study period of five years (2014–2018) 3,445 participants were enrolled in the study cohort, of which 884 (25%) were from Chulaimbo, 808 (23%) from Kisumu, 736 (21%) from Msambweni and 1,016 (29%) from Ukunda. The number of participants from the less densely populated communities (Chulaimbo and Msambweni (1692, 47%)) and more densely populated communities (Kisumu and Ukunda, (1,752, 50.8%)) were similar. Moreover, the number of participants living on the coast (1753, 50.8%) and west (1692, 49.1%) were also comparable. The median age of the study participants was 8 years (IQR: 5–10 years) with a similar proportion of male (1615, 46.8%) and female (1674, 48.5%) participants. The wealth scoring index classified wealth into 4 indices with index 4 implying a high SES comprised of 963 (27.9%) households and index 1 implying a low SES with 1,073 (31.1%) households (Distribution of wealth index is provided in Table 1). The crowding index was more pronounced in more densely populated areas than in less densely populated areas (p-value <0.05). Approximately 25% of the children had travelled in the last six months and ~36% children used any kind of mosquito prevention methods including coil, repellent or spray categorized to create the mosquito index (see methods). The study characteristics and population behaviors are shown in Table 1.

Table 1. Characteristics and behavior of the population and households in the four villages in Kenya (2014–2018).


Predictors
Chulaimbo
N (%)
Kisumu
N (%)
Ukunda
N (%)
Msambweni
N (%)
Total population
N (%)
Coast West
Age group at recruitment (years)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
missing

1 (0.1%)
23 (2.6%)
79 (8.9%)
79 (8.9%)
84 (9.5%)
86 (9.7%)
91 (10.2%)
90 (10.1%)
65 (7.3%)
71 (8%)
71 (7%)
78 (8.8%)
30 (3.4%)
12 (1.3%)
6 (0.6%)
1 (0.1%)
17 (1.9%)

0 (0%)
28 (3.4%)
87 (10.7%)
80 (9.9%)
76 (9.4%)
72 (8.9%)
73 (9%)
68 (8.4%)
87 (10.7%)
73 (9.03%)
44 (5.4%)
59 (7.3%)
43 (5.3%)
33 (4.1%)
6 (0.7%)
0 (0%)
21 (2.5%)

4 (0.4%)
18 (1.7%)
48 (4.7%)
79 (7.7%)
94 (9.2%)
105 (10.3%)
99 (9.7%)
90 (8.8%)
102 (10.0%)
77 (7.5%)
80 (7.8%)
57 (5.6%)
66 (6.5%)
17 (1.2%)
6 (0.5%)
2 (0.2%)
73 (7.1%)

0 (0%)
18 (2.4%)
51(7.1%)
72 (9.9%)
71 (9.6%)
67 (9.1%)
52 (7.1%)
62 (8.4%)
56 (7.6%)
68 (9.2%)
74 (10.1%)
63 (8.5%)
31 (4.2%)
4 (0.5%)
2 (0.3%)
2 (0.3%)
43 (5.8%)

5 (0.14%)
87 (0.3%)
265 (7.6%)
310 (8.9%)
325 (9.4%)
330 (9.6%)
315 (9.1%)
310 (8.9%)
310 (8.9%)
289 (8.4%)
269 (7.8%)
257 (7.4%)
170 (4.9%)
66 (1.9%)
20 (0.5%)
5 (0.14%)
154 (4.4%)
Gender
Female
Male
Missing

405 (45.8%)
459 (51.9%)
20 (2.2%)

432 (53.4%)
355 (43.9%)
21 (2.6%)

509 (50%)
437 (42.9%)
72 (7.07%)

328 (44.5%)
364 (49.4%)
44 (5.9%)

1674 (48.5%)
1615 (46.8%)
157 (4.5%)
More dense site
Less dense site
0
884 (100%)
808 (100%)
0
1017(100%)
0
0
736 (100%)
1825 (52.9%)
1620 (47.0%)
Crowding indexa
1–2
= >3
missing

701 (79.2%)
96 (10.8%)
87 (9.8%)

316 (39.1%)
410 (50.7%)
82 (10.1%)

570 (56%)
370 (36.3%)
77 (7.5%)

630 (85.6%)
60 (8.1%)
46 (6.2%)

2217 (64.3%)
936 (27.1%)
292 (8.4%)
Water buckets in house
Yes
No

486 (54.9%)
398 (45.0%)

457 (56.5%)
351 (43.4%)

222 (21.8%)
795 (78.1%)

516 (70.1%)
220 (29.9%)

1681 (48.7%)
1764 (51.2%)
Wealth index
Index 1 (lowest)
Index 2
Index 3
Index 4 (highest)

264 (29.8%)
389 (44%)
145 (16.4%)
86 (9.7%)

91 (11.2%)
113 (14%)
162 (20.0%)
442 (54.7%)

549 (53.9%)
103 (10.2%)
53 (5.2%)
31 (3.04%)

169 (22.9%)
223 (30.2%)
221 (30.0%)
404 (54.9%)

1073 (31.1%)
828 (24.03%)
581 (16.7%)
963 (27.9%)
Travelb
Yes
No

274 (30.9%)
610 (69.0%)

435 (53.8%)
373 (461.6%)

247 (24.2%)
770 (75.7%)

240 (32.6%)
496 (67.3%)

1196 (34.7%)
2249 (65.3%)
Outdoor time
Yes
No
missing

698 (78.9%)
95 (10.7%)
91 (10.3%)

479 (59.3%)
223 (27.6%)
106 (13.1%)

545 (53.6%)
3 (0.3%)
469 (46.1%)

534 (72.5%)
1 (0.1%)
201 (27.3%)

2256 (65.4%)
322 (9.3%)
867 (25.1%)
Trash in the housing compound
Yes
No

381 (43.1%)
503 (56.9%)

271 (33.5%)
537 (66.5%)

38 (3.7%)
979 (96.2%)

293 (39.8%)
443 (60.2%)

983 (28.5%)
2462 (71.4%)
Use of window screens
Yes
No
missing

200 (22.6%)
597 (67.5%)
87 (9.8%)

152 (18.8%)
574 (71.03%)
82 (10.1%)

746 (73.3%)
194 (19.1%)
77 (7.5%)

386 (52.4%)
289 (39.3%)
61 (8.2%)

1484 (43.1%)
1654 (48.0%)
307 (8.9%)
Mosquito indexc
0
1

748 (84.6%)
136 (15.4%)

656 (81.1%)
152 (18.7%)

988 (97.1%)
29 (2.8%)

727 (98.7%)
9 (1.2%)

3119 (90.5%)
326 (9.4%)

a Crowding index is composed of number of people living in the house divided by the number of rooms in the house

b Travel indicates the travel of a child more than 10 km from the site of their residence in the last six months

c Mosquito index comprises of the usage of mosquito coil, mosquito repellent or mosquito spray by the children

DENV and CHIKV IgG seroprevalence

In total, 181 (5.3%) study participants tested positive for DENV IgG with the highest number of participants recorded in Msambweni (75, 41.4%) followed by Ukunda (45, 24.8%), Chulaimbo (40, 22%) and Kisumu (21, 11.6%) (Fig 2). DENV seropositivity was similar for male and female participants (5.8% vs 5.4%, p-value = 0.4) with ~16% of DENV seropositive cases observed among the participants within age groups 0–5 years. DENV seroprevalence exhibited an increase from 2014–2017 with a decline in 2018 (Table B in S1 Text). In contrast, a total of 320 (9.2%) participants tested positive for the CHIKV IgG with the highest number of cases reported in Chulaimbo (185, 57.8%) followed by Msambweni (64, 20%), Kisumu (42, 13.1%), and Ukunda (29, 9.0%) (Fig 2). The proportion of female CHIKV seropositive participants was higher than males (9.2% vs 11.4%, p-value = 0.06) with the fewer number of CHIKV seropositive cases between ages of 0–5 years. A minority of participants (28; 0.81%) were seropositive for both DENV and CHIKV IgG, suggesting exposure to both viruses.

Fig 2. DENV and CHIKV seropositivity and seroconversion status of the study participants from the longitudinal cohort in Kenya by each village, 2014–2018.

Fig 2

Association between DENV and CHIKV seroprevalence and potential risk factors

In the univariable analysis, higher age, living in a western site and densely populated areas, presence of water containers at home, crowding and a higher wealth index were significantly associated with DENV seropositivity (Table C in S1 Text). For CHIKV seropositivity, the univariable analysis showed higher age, male gender, living in the western site and densely populated areas, household crowding, presence of water containers, higher wealth, presence of trash in the compound, and the presence of window screens to be significantly associated with CHIKV seropositivity (Table C in S1 Text).

Age, gender, the presence of water buckets in the house, wealth index, child travel and presence of trash in the compound were included in the best GLMM for seropositivity. The association of the selected variables was similar for DENV and CHIKV seropositivity in the multivariable analysis. Older age and the presence of water containers ((OR: 1.15 [95% CI: 1.10, 1.21]), (OR: 1.50 [95% CI: 1.07, 2.10])) increased the odds of DENV seropositivity, whereas higher wealth (OR: 0.83 [95% CI: 0.73, 0.96]) decreased odds of DENV seropositivity (Table 2). Similarly, older age and the presence of trash in the compound were associated with increased odds of CHIKV seropositivity ((OR: 1.11 [95% CI: 1.07, 1.15]) and (OR: 1.34 [95% CI:1.04, 1.73]) respectively), while higher wealth was associated with decreased odds of CHIKV seropositivity (OR: 0.74 [95% CI:0.66, 0.83]) (Table 2).

Table 2. Multivariable GLMM analysis of the risk factors associated with DENV and CHIKV seroprevalence.

Predictor DENV seropositivity
OR (95% CI)b
CHIKV seropositivity
OR (95% CI)b
Age 1.15 (1.10, 1.21)*** 1.11 (1.07, 1.15)***
Male 1.07 (0.79, 1.46) 1.14 (0.89, 1.45)
Presence of water buckets in house 1.50 (1.07, 2.10)* 1.21 (0.94, 1.56)
Wealth index 0.83 (0.73, 0.96)** 0.74 (0.66, 0.83)**
Child travela 1.20 (0.87, 1.66) 0.93 (0.73, 1.20)
Presence of trash in compound 0.93 (0.65, 1.33) 1.34 (1.04, 1.73)*

*Indicates a statistically significant p-value, 0.05*, 0.01**, 0.001***

a Travel indicates the travel of a child more than 10km from home in the last six months

b Odds ratio (95% Confidence Interval)

DENV and CHIKV IgG seroconversion

From 2014 to 2018, 107 (3.1%) participants seroconverted for DENV with the highest number of seroconversions recorded in Msambweni (42, 39.2%) followed by Chulaimbo (30, 28%), Ukunda (18, 16.8%) and Kisumu (17, 15.8%) (Fig 2). Most participants seroconverted in 2017 (40, 37.3%), followed by year 2016 (38, 35.5%), and 2015 (27, 25.2%). Of the 107 participants who seroconverted, 49 (45.7%) were females and 58 (54.2%) were males. From 2014 to 2018, 174 (5.05%) participants seroconverted for CHIKV with the highest number of seroconversions recorded in Chulaimbo (89, 51.1%), followed by Msambweni (49, 28.1%), Kisumu (19, 10.9%) and Ukunda (17, 9.7%) (Fig 2). Most participants seroconverted in 2015 (59, 33.9%) followed by 2016 (57, 32.7%) and 2017 (50, 28.8%). There was a marginal difference in seroconversions between male participants (90, 51.7%) and female participants (84, 48.2%).

Association between DENV and CHIKV seroconversion and potential risk factors

In the univariable analysis for DENV seroconversion, higher age, living in an urban area, household crowding, the presence of water containers in the household, and history of travel were significantly associated with DENV seroconversion (Table D in S1 Text). Subsequently, for the univariable analysis for CHIKV seroconversion, living in the western and densely populated sites, household crowding, the presence of water containers and window screens, trash in the compound, and travel were significantly associated with CHIKV seroconversion. Higher wealth was found to decrease the odds of CHIKV seroconversion (Table D in S1 Text).

Age, gender, presence of water buckets in the house, wealth index, child travel and presence of trash in the compound were included in the best model for seroconversion. The association of the selected variables was similar for DENV and CHIKV seroconversion in the multivariable analysis. A higher wealth index (OR: 0.82 [95% CI: 0.69, 0.97]) was associated with decreased odds of DENV seroconversion, whereas a higher age (OR: 1.08 [95% CI: 1.02, 1.15]) and the presence of water containers in the household (OR: 1.91[95% CI: 1.24, 2.95]) were significantly associated with an increased odds of DENV seroconversion (Table 3). Similar to the DENV seroconversion model, the CHIKV seroconversion model also showed a decrease in the odds of CHIKV seroconversion (OR: 0.75 [95% CI: 0.66, 0.89]) in wealthier households and an increased odds of CHIKV seroconversion with the presence of water containers in the house (OR: 1.57 [95% CI: 1.11, 2.21]). The presence of surrounding trash was associated with CHIKV seroconversion, although not statistically significantly (Table 3).

Table 3. Multivariable GLMM analysis of the risk factors associated with DENV and CHIKV seroconversion.

Predictor DENV seroconversion
OR (95% CI)b
CHIKV seroconversion
OR (95% CI)b
Age 1.08 (1.02, 1.15)* 1.02 (0.97, 1.07)
Male 1.19 (0.81, 1.76) 1.12 (0.82, 1.54)
Presence of water buckets in house 1.91 (1.24, 2.95)** 1.57 (1.11, 2.21)**
Wealth index 0.82 (0.68, 0.97)* 0.76 (0.66, 0.88)***
Child travela 0.89 (0.59, 1.36) 1.19 (0.86, 1.65)
Presence of trash in compound 1.41 (0.95, 2.09) 1.35 (0.97, 1.88)

*Indicates a statistically significant p-value, 0.05*, 0.01**, 0.001***

a Travel indicates the travel of a child more than 10km from home in the last six months

b Odds ratio (95% Confidence Interval)

Survival analysis for DENV and CHIKV

The results from the Kaplan Meier curves for DENV showed that the fraction of seroconversions for the first year was <2%. By the fourth year into the study the fraction of seroconversions had risen to <27% (Fig 3A). The Kaplan Meier curves were compared for three groups: (i) the four villages, (ii) coast and west and (iii) by “urban” (more densely populated) and “rural” (less densely populated) sites. However, the log rank test showed no statistically significant differences between any groups for DENV seroconversion (Fig 3B, 3C and 3D). The results from the Kaplan Meier curves of CHIKV also showed that the fraction of seroconversion for the first year was <2% with a substantial increase by the fourth year to <42% (Fig 4A). The log rank test showed statistically significant difference in the survival times to seroconversion between the four villages (Log rank, p<0.01). Similarly, the long rank test also showed statistically significant difference in the survival times to seroconversion between coast and west (Log rank, p<0.01) and urban and rural sites (Log rank, p<0.01) (Fig 4B, 4C and 4D).

Fig 3.

Fig 3

Panel A. Overall survival probability for the participants who seroconverted for DENV. Panel B. Survival probability for the participants who seroconverted for DENV by the village. Panel C. Survival probability for the participants who seroconverted for DENV by “urban” (more densely populated) and “rural” (less densely populated) location. Panel D. Survival probability for the participants who seroconverted for DENV by the region.

Fig 4.

Fig 4

Panel A. Overall survival probability for the participants who seroconverted for CHIKV. Panel B. Survival probability for the participants who seroconverted for CHIKV by village. Panel C. Survival probability for the participants who seroconverted for CHIKV by “urban” (more densely populated) and “rural” (less densely populated) location. Panel D. Survival probability for the participants who seroconverted for CHIKV by region.

Discussion

CHIKV and DENV are closely related mosquito-borne viruses with similar transmission cycles, vectors and disease manifestations that render them difficult to distinguish without appropriate diagnostic testing. The findings of this study underscore the continued transmission of these arboviruses among children in Kenya with a 9.3% seroprevalence of CHIKV and 5.3% seroprevalence of DENV. Additionally, we observed seroconversions throughout the five years suggesting ongoing CHIKV and DENV transmission in children during the study period. The rate of seroconversions for DENV was the lowest in 2015 followed by 2016 and 2017 is when 37% of the seroconversion occurred in our study. On the contrary for CHIKV, the highest number of seroconversions were observed in 2015 (33.9%) followed by a decline in seroconversions to 28.7% by 2017. A notable difference was observed in the seroprevalence and seroconversion rates within different villages at the respective sites, with a greater number of cases detected in the less densely populated regions (Msambweni and Chulaimbo). These findings are less consistent with the past central dogma of dengue epidemiology associating dengue exposure with densely populated (urban) regions and more consistent with changes in the epidemiology seen in tropical regions around the world, where the burden of dengue in rural classified regions is almost as high as urban areas [4,1823]. We also found increased seroprevalence of CHIKV in the west and increased seroprevalence of DENV on the coast, which we have previously described [12,13,24]. With the changing epidemiology and spread of arboviruses to newer regions, children remain at risk for new infections, especially in the setting of outbreaks. It is imperative to better understand the risk factors for these viruses to help mitigate spread and transmission of these viruses as much as possible.

In this study, we documented a preponderance of exposure and incident CHIKV and DENV infections in children in rural areas. This may be partly related to increased urbanization and travel in the rural areas; however, increased testing and surveillance in rural regions has uncovered a high burden of exposure [21,23,25]. Viral circulation through population mobility and increasingly permissive environments for vector species likely contributes to increased homogeneity in dengue risk across diverse settings including the rural environments.

Arboviruses have been associated with poverty related socio-economic factors and this is likely multifactorial, including less means to purchase preventive measures (window screens, repellants, bed nets), substandard built environment, household crowding, and reliance on water collection for water access [2630]. The lowest wealth quartile group was at higher risk for both DENV and CHIKV exposure and incident infection. The two rural sites in this study have considerably lower wealth compared to the urban communities in the respective regions [26]. Our prior studies have also shown increased vector abundance in less densely populated areas which contributes to the transmission dynamics of these viruses [31,32]. The difference in risk of exposure between sites is at least partly due to poverty as defined by home building materials, non-paved roads, inadequate water sources, and lack of preventative measures against mosquitoes, all of which are statistically significant differences between the adjacent villages. While it is important to note that the overall wealth in all four study sites is generally low, the poorest within any village were still most at risk.

Access to waste management can also be tied to wealth, but trash can act as an independent risk factor for Aedes aegypti breeding [33,34]. In the multivariable analysis, trash was linked to low wealth, and associated with increased risk for seropositivity and seroconversion for both viruses. Surrounding environmental trash, especially plastic containers, can serve as optimal habitat for vector breeding and proliferation causing increased exposure to these viruses [13,33,35]. Waste management and water access inequities are important to address in the community to minimize exposure to arboviral threats. DENV seroprevalence was associated with the presence of water containers in the households, a sign of inadequate water supply, which can lead to increased vector breeding and abundance [5,6,36]. New infections (seroconversions) for both viruses were also linked to improper water storage practices, increasing mosquito breeding sites that leads to increased risk of DENV and CHIKV infections.

As expected, increasing age was associated with increased risk of exposure for both viruses and also with seroconversions, given that older children are more mobile in the community [10,37]. Given that Aedes spp. mosquitoes exhibit day biting behavior, this risk can also be associated with more time spent outdoors by older children, especially given prior studies that show the preponderance of vectors to be outdoors instead of indoors in our study regions [38]. Our pediatric study did not show a difference in CHIKV or DENV seroprevalence or seroconversion between genders, which differs from reports in adults where males were at a higher risk for both DENV and CHIKV infection [39,40]. This may be related to gendered roles in the community that lead to varied risk of exposure in adulthood.

Yearly seroconversion rates were low, yet consistent, for both CHIKV and DENV among the children, highlighting a stable endemic pattern of CHIKV and DENV transmission in Kenya. A significant difference was observed in the CHIKV seroconversion rates between different sites, urban and rural designation, and coast and west geography, likely because of the higher number of participants that seroconverted for CHIKV. As stated, there are fundamental differences between the respective sites on the coast and in the west and link to factors that may affect wealth in addition to direct mosquito exposure. In contrast, no significant differences between comparator groups were seen in the seroconversion rates for DENV which may have been due to a limited number of DENV seroconversions in the study.

Improving efforts to detect DENV and CHIKV infections and regular surveillance in Kenya will raise awareness of DENV and CHIKV and increase the likelihood that healthcare providers will suspect it in patients. Correct diagnoses can inform public health ministries to detect and react to outbreaks of DENV and CHIKV illnesses, potentially circumventing cycles of missed opportunities for preventive interventions. Formulation of an active surveillance system for DENV and CHIKV detection will allow the health ministry to gauge the actual daily burden of these diseases among the population, better informing the public health policies, including the use of regular pesticides and larvicides to kill mosquitoes and their larvae, elimination of mosquito breeding habitats, managing stagnant water areas, and educating the population about the use of mosquito repellents, bed nets and window screens, and cleaning up of the trash.

The major strength of this study is the incorporation of four study sites covering rural and urban settings in coastal and western Kenya and following a cohort of 3445 children for the first time over 5 years to assess the CHIKV and DENV IgG status and associated risk factors at our study sites. However, there are several limitations of this study. Due to multiple missing responses over the follow-up visits, the data for the purpose of this analysis was utilized as a cross-sectional snap-shot, by combining the responses at the base-line and follow up visits over time. Heterogeneity in responses to predictors included in the analysis was also checked and no marked difference was observed among the population over time. DENV is co-circulating with other flaviviruses and CHIKV is co-circulating with other alphaviruses in this region and IgG can cross react with those related viruses, including Zika virus, yellow fever virus, and West Nile virus for dengue and o’nyong-nyong virus for chikungunya [11,12,24,41,42]. Prior PRNT testing in these areas has documented that DENV and CHIKV remain the most likely flaviviruses and alphaviruses in the region; however no PRNT testing was done for confirmation in this study, so a small amount of misclassification bias may be present [1012]. Confirmation of acute infections by real time reverse transcriptase polymerase chain reaction (rRT-PCR) testing would have increased specificity. An initial dropout of participants required additional recruitment during the first follow-up visit, so a proportion of the children were only followed for 4.5 years. This study evaluated exposure to infection in children, who may have different risk factors than adults, and therefore study results may not be generalizable to all individuals. More studies including adults in the sample size are needed to understand the seroprevalence and risk factors for DENV and CHIKV in the adult population. In this longitudinal surveillance study, the self-reported behaviors of the study participants could also lead to response bias.

Conclusion

Our study underscores continued low level DENV and CHIKV transmission among children in Kenya and the association with indicators of poverty: belonging to a low socio-economic stratum, presence of trash on the housing compound and collection of water in containers. These findings with associated risk factors can be helpful when attempting to implement preventive measures from the Ministry of Health. Some elements can be better targeted and there can be community campaigns to reinforce changes that may help mitigate transmission. As our study demonstrates a significant burden of CHIKV and DENV infection in Kenya, we suggest improving the current focal public health and control activities by (1) establishing community sentinel site surveillance and health center-based surveillance for CHIKV and DENV, (2) establishing a permanent vector control program and (3) continuing public education on DENV and CHIKV prevention measures (e.g., elimination of discarded used tires, emptying water containers, removing trash from the surroundings etc.) [43]. Additionally, committed political involvement is essential to direct enough resources to improve socioeconomic conditions of the less privileged communities if a change in epidemic patterns is to be expected. Children remain at risk for further outbreaks from either virus, demonstrating the importance of improved diagnostics and ongoing surveillance. This study underscores the need for regular DENV and CHIKV surveillance in DENV and CHIKV endemic areas, such as Kenya, Sudan, Ethiopia, Chad and Nigeria as well as further studies including adults in the population to determine the burden of these arboviral diseases in the adult population. With the hope of potential vaccinations for both viruses on the horizon, it is vital to continue to better understand these infections to decrease the burden in various communities, especially vulnerable populations, and to provide insight to optimize the implementation of any future vaccine.

Supporting information

S1 Text. Supplementary File.

(DOCX)

pntd.0012616.s001.docx (19.9KB, docx)

Data Availability

The datasets generated and/or analyzed during the current study are available from the github repository: https://github.com/atariq2891/Kenya-CHIKV-and-DENV-data-2014-2018.

Funding Statement

Salary support for A.T., D.B., F.M., B.N., E.G., Z.J., P.M., P.C., C.R., V.O., A.D.L. was provided by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, R01 (AI102918). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Furuya-Kanamori L, Liang S, Milinovich G, Soares Magalhaes RJ, Clements ACA, Hu W, et al. Co-distribution and co-infection of chikungunya and dengue viruses. BMC Infect Dis. 2016. Mar 3;16:84. doi: 10.1186/s12879-016-1417-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Zeller H, Van Bortel W, Sudre B. Chikungunya: Its History in Africa and Asia and Its Spread to New Regions in 2013–2014. J Infect Dis. 2016. Dec 15;214(suppl 5):S436–40. doi: 10.1093/infdis/jiw391 [DOI] [PubMed] [Google Scholar]
  • 3.Amarasinghe A, Kuritsk JN, Letson GW, Margolis HS. Dengue virus infection in Africa. Emerg Infect Dis. 2011. Aug;17(8):1349–54. doi: 10.3201/eid1708.101515 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Were F. The dengue situation in Africa. Paediatr Int Child Health. 2012. May;32 Suppl 1:18–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Ngugi HN, Mutuku FM, Ndenga BA, Musunzaji PS, Mbakaya JO, Aswani P, et al. Characterization and productivity profiles of Aedes aegypti (L.) breeding habitats across rural and urban landscapes in western and coastal Kenya. Parasit Vectors. 2017. Jul 12;10(1):331. doi: 10.1186/s13071-017-2271-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Ngugi HN, Nyathi S, Krystosik A, Ndenga B, Mbakaya JO, Aswani P, et al. Risk factors for Aedes aegypti household pupal persistence in longitudinal entomological household surveys in urban and rural Kenya. Parasit Vectors. 2020. Oct 1;13(1):499. doi: 10.1186/s13071-020-04378-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Khan A, Ndenga B, Mutuku F, Bosire CM, Okuta V, Ronga CO, et al. Majority of pediatric dengue virus infections in Kenya do not meet 2009 WHO criteria for dengue diagnosis. PLOS Glob Public Health. 2022. Apr 20;2(4):e0000175. doi: 10.1371/journal.pgph.0000175 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Lim JK, Matendechero SH, Alexander N, Lee JS, Lee KS, Namkung S, et al. Clinical and epidemiologic characteristics associated with dengue fever in Mombasa, Kenya. Int J Infect Dis. 2020. Nov;100:207–15. doi: 10.1016/j.ijid.2020.08.074 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Ng RJ, Chong ZL, Abdul Mutalip MH, Ng CW. Dengue Seroprevalence and Factors Associated with Dengue Seropositivity in Petaling District, Malaysia. Int J Environ Res Public Health. 2022. Jun 11;19(12):7170. doi: 10.3390/ijerph19127170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.LaBeaud AD, Banda T, Brichard J, Muchiri EM, Mungai PL, Mutuku FM, et al. High rates of o’nyong nyong and Chikungunya virus transmission in coastal Kenya. PLoS Negl Trop Dis. 2015. Feb;9(2):e0003436. doi: 10.1371/journal.pntd.0003436 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Hortion J, Mutuku FM, Eyherabide AL, Vu DM, Boothroyd DB, Grossi-Soyster EN, et al. Acute Flavivirus and Alphavirus Infections among Children in Two Different Areas of Kenya, 2015. Am J Trop Med Hyg. 2019;100(1):170–3. doi: 10.4269/ajtmh.18-0297 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Grossi-Soyster EN, Cook EAJ, Glanville WA, Thomas LF, Krystosik AR, Lee J, et al. Serological and spatial analysis of alphavirus and flavivirus prevalence and risk factors in a rural community in western Kenya. PLoS Negl Trop Dis. 2017. Oct 17;11(10):e0005998. doi: 10.1371/journal.pntd.0005998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Khan A, Bisanzio D, Mutuku F, Ndenga B, Grossi-Soyster EN, Jembe Z, et al. Spatiotemporal overlapping of dengue, chikungunya, and malaria infections in children in Kenya. BMC Infect Dis. 2023. Mar 29;23:183. doi: 10.1186/s12879-023-08157-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Friesen CE, Seliske P, Papadopoulos A. Using Principal Component Analysis to Identify Priority Neighbourhoods for Health Services Delivery by Ranking Socioeconomic Status. Online J Public Health Inform. 2016;8(2):e192. doi: 10.5210/ojphi.v8i2.6733 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Cnaan A, Laird NM, Slasor P. Using the general linear mixed model to analyse unbalanced repeated measures and longitudinal data. Stat Med. 1997. Oct 30;16(20):2349–80. doi: [DOI] [PubMed] [Google Scholar]
  • 16.Faruk MO, Jannat SN, Rahman MdS. Impact of environmental factors on the spread of dengue fever in Sri Lanka. Int J Environ Sci Technol. 2022;19(11):10637–48. doi: 10.1007/s13762-021-03905-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.R: The R Project for Statistical Computing [Internet]. [cited 2023 Jun 26]. Available from: https://www.r-project.org/.
  • 18.Chew CH, Woon YL, Amin F, Adnan TH, Abdul Wahab AH, Ahmad ZE, et al. Rural-urban comparisons of dengue seroprevalence in Malaysia. BMC Public Health. 2016. Aug 18;16(1):824. doi: 10.1186/s12889-016-3496-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Schmidt WP, Suzuki M, Dinh Thiem V, White RG, Tsuzuki A, Yoshida LM, et al. Population Density, Water Supply, and the Risk of Dengue Fever in Vietnam: Cohort Study and Spatial Analysis. PLoS Med. 2011. Aug 30;8(8):e1001082. doi: 10.1371/journal.pmed.1001082 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Doum D, Overgaard HJ, Mayxay M, Suttiprapa S, Saichua P, Ekalaksananan T, et al. Dengue Seroprevalence and Seroconversion in Urban and Rural Populations in Northeastern Thailand and Southern Laos. Int J Environ Res Public Health. 2020. Dec;17(23):9134. doi: 10.3390/ijerph17239134 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tewari SC, Thenmozhi V, Katholi CR, Manavalan R, Munirathinam A, Gajanana A. Dengue vector prevalence and virus infection in a rural area in south India. Trop Med Int Health. 2004;9(4):499–507. doi: 10.1111/j.1365-3156.2004.01103.x [DOI] [PubMed] [Google Scholar]
  • 22.Shah PS, Deoshatwar A, Karad S, Mhaske S, Singh A, Bachal RV, et al. Seroprevalence of dengue in a rural and an urbanized village: A pilot study from rural western India. J Vector Borne Dis. 2017. Jun;54(2):172–6. [PubMed] [Google Scholar]
  • 23.Man O, Kraay A, Thomas R, Trostle J, Lee GO, Robbins C, et al. Characterizing dengue transmission in rural areas: A systematic review. PLoS Negl Trop Dis. 2023. Jun;17(6):e0011333. doi: 10.1371/journal.pntd.0011333 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Shah MM, Ndenga BA, Mutuku FM, Vu DM, Grossi-Soyster EN, Okuta V, et al. High Dengue Burden and Circulation of 4 Virus Serotypes among Children with Undifferentiated Fever, Kenya, 2014–2017. Emerg Infect Dis. 2020. Nov;26(11):2638–50. doi: 10.3201/eid2611.200960 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Kolimenakis A, Heinz S, Wilson ML, Winkler V, Yakob L, Michaelakis A, et al. The role of urbanisation in the spread of Aedes mosquitoes and the diseases they transmit-A systematic review. PLoS Negl Trop Dis. 2021. Sep;15(9):e0009631. doi: 10.1371/journal.pntd.0009631 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kikuti M, Cunha GM, Paploski IAD, Kasper AM, Silva MMO, Tavares AS, et al. Spatial Distribution of Dengue in a Brazilian Urban Slum Setting: Role of Socioeconomic Gradient in Disease Risk. PLoS Negl Trop Dis. 2015;9(7):e0003937. doi: 10.1371/journal.pntd.0003937 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Thammapalo S, Chongsuvivatwong V, Geater A, Dueravee M. Environmental factors and incidence of dengue fever and dengue haemorrhagic fever in an urban area, Southern Thailand. Epidemiol Infect. 2008. Jan;136(1):135–43. doi: 10.1017/S0950268807008126 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Resendes AP da C, Silveira NAPR da, Sabroza PC, Souza-Santos R. Determination of priority areas for dengue control actions. Rev Saude Publica. 2010. Apr;44(2):274–82. doi: 10.1590/s0034-89102010000200007 [DOI] [PubMed] [Google Scholar]
  • 29.Mascarenhas M, Garasia S, Berthiaume P, Corrin T, Greig J, Ng V, et al. A scoping review of published literature on chikungunya virus. PLoS ONE [Internet]. 2018. Nov 29 [cited 2020 Jan 18];13(11). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6264817/. doi: 10.1371/journal.pone.0207554 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Kiener M, Cudjoe N, Evans R, Mapp-Alexander V, Tariq A, Macpherson C, et al. Factors Associated with Chikungunya Infection among Pregnant Women in Grenada, West Indies. Am J Trop Med Hyg. 2023. Jul 5;109(1):123–5. doi: 10.4269/ajtmh.23-0157 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Weetman D, Kamgang B, Badolo A, Moyes CL, Shearer FM, Coulibaly M, et al. Aedes Mosquitoes and Aedes-Borne Arboviruses in Africa: Current and Future Threats. Int J Environ Res Public Health. 2018. Feb;15(2):220. doi: 10.3390/ijerph15020220 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Gainor EM, Harris E, LaBeaud AD. Uncovering the Burden of Dengue in Africa: Considerations on Magnitude, Misdiagnosis, and Ancestry. Viruses. 2022. Jan 25;14(2):233. doi: 10.3390/v14020233 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Forsyth JE, Mutuku FM, Kibe L, Mwashee L, Bongo J, Egemba C, et al. Source reduction with a purpose: Mosquito ecology and community perspectives offer insights for improving household mosquito management in coastal Kenya. PLoS Negl Trop Dis. 2020. May;14(5):e0008239. doi: 10.1371/journal.pntd.0008239 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Krystosik A, Njoroge G, Odhiambo L, Forsyth JE, Mutuku F, LaBeaud AD. Solid Wastes Provide Breeding Sites, Burrows, and Food for Biological Disease Vectors, and Urban Zoonotic Reservoirs: A Call to Action for Solutions-Based Research. Front Public Health. 2019;7:405. doi: 10.3389/fpubh.2019.00405 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Forsyth JE, Kempinsky A, Pitchik HO, Alberts CJ, Mutuku FM, Kibe L, et al. Larval source reduction with a purpose: Designing and evaluating a household- and school-based intervention in coastal Kenya. PLoS Negl Trop Dis. 2022. Apr;16(4):e0010199. doi: 10.1371/journal.pntd.0010199 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Mwakutwaa AS, Ngugi HN, Ndenga BA, Krystosik A, Ngari M, Abubakar LU, et al. Pupal productivity of larval habitats of Aedes aegypti in Msambweni, Kwale County, Kenya. Parasitol Res. 2023. Jan 23; doi: 10.1007/s00436-022-07777-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Tam CC, Tissera H, de Silva AM, De Silva AD, Margolis HS, Amarasinge A. Estimates of dengue force of infection in children in Colombo, Sri Lanka. PLoS Negl Trop Dis. 2013;7(6):e2259. doi: 10.1371/journal.pntd.0002259 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ndenga BA, Mutuku FM, Ngugi HN, Mbakaya JO, Aswani P, Musunzaji PS, et al. Characteristics of Aedes aegypti adult mosquitoes in rural and urban areas of western and coastal Kenya. PloS One. 2017;12(12):e0189971. doi: 10.1371/journal.pone.0189971 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Prasith N, Keosavanh O, Phengxay M, Stone S, Lewis HC, Tsuyuoka R, et al. Assessment of gender distribution in dengue surveillance data, the Lao People’s Democratic Republic. West Pac Surveill Response J WPSAR. 2013. May 21;4(2):17–24. doi: 10.5365/WPSAR.2012.3.4.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Omatola CA, Onoja BA, Fassan PK, Osaruyi SA, Iyeh M, Samuel MA, et al. Seroprevalence of chikungunya virus infection in five hospitals within Anyigba, Kogi State of Nigeria. Braz J Infect Dis. 2020. Jan 1;24(1):1–6. doi: 10.1016/j.bjid.2020.01.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Shah MM, Ndenga BA, Mutuku FM, Okuta V, Ronga CO, Chebii PK, et al. No Evidence of O’nyong-nyong Viremia among Children with Febrile Illness in Kenya (2015–2018). Am J Trop Med Hyg. 2021. Feb 22;104(4):1435–7. doi: 10.4269/ajtmh.20-0580 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Waggoner J, Brichard J, Mutuku F, Ndenga B, Heath CJ, Mohamed-Hadley A, et al. Malaria and Chikungunya Detected Using Molecular Diagnostics Among Febrile Kenyan Children. Open Forum Infect Dis. 2017;4(3):ofx110. doi: 10.1093/ofid/ofx110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Velasco-Salas ZI, Sierra GM, Guzmán DM, Zambrano J, Vivas D, Comach G, et al. Dengue Seroprevalence and Risk Factors for Past and Recent Viral Transmission in Venezuela: A Comprehensive Community-Based Study. Am J Trop Med Hyg. 2014. Nov 5;91(5):1039–48. doi: 10.4269/ajtmh.14-0127 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012616.r001

Decision Letter 0

Andrea Marzi, Chaturaka Rodrigo

22 Mar 2024

Dear Dr. Tariq,

Thank you very much for submitting your manuscript "Risk factors associated with dengue virus and chikungunya virus

seropositivity and seroconversion among children in Kenya, a longitudinal study" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Chaturaka Rodrigo, MD PhD FRCP

Academic Editor

PLOS Neglected Tropical Diseases

Andrea Marzi

Section Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: The statistical methods that were used in determining results, such as logistic regression and Kaplan-Meier analysis, were not clearly described.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: They attempted to identify the predictors of DENV and CHIKV seroprevalence and seroconversion and describe the temporal patterns of DENV and CHIKV seroconversion. However, the authors did not adequately describe the rationale, significance, and inclusion and exclusion criteria of the study.

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: The authors should clearly demonstrate the novel findings of their study in the body of literature. This could be achieved by highlighting how their study adds to existing literature and identifying any new or significant findings.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: In this prospective cohort study, authors aim to identify non-biological risk factors associated with DENV/CHIKV infection in Kenyan children, diseases causing less morbidity/mortality in Kenya compared to other endemic countries. It is a novel/significant study given the uncharacterised behaviour of these infections in sub-Saharan countries and also a major effort considering the study was conducted for five years.

Unfortunately, results are unnecessarily extended, making repetitive and uninformative sections that are closely related (e.g., seroprevalence and incidence) or don't have a fundamental implication for policy-making. What is the usefulness of exploring seroprevalence and seroconversion separately? Despite these informing different phenomena (e.g., symptomatic vs asymptomatic infection), how is this data expected to help policy-making or public health? Too many tables and a massive amount of figures make the manuscript overwhelming and lose perspective. Authors should focus on one aspect, justifying the selection by evidence, and remake the result section to make it friendly and catchy.

Major Issues: - As exposed in the previous section, results are unnecessarily long and should be restricted to one relevant and major aspect: seroprevalence or seroconversion. Additional data could be included as supplementary in case readers are interested in specific details.

- Statistical analysis: I agree with the authors in using PCA to reduce multiple variables and create specific scores. However, these artificial new variables need to be validated against an independent variable to confirm new scores are solid and actually capturing what is expected. Just as an example, if there's a correlation between the SES and yearly/weekly income, there's solid evidence of the usefulness of the new scores.

Minor Issues: - In Table 3, the gender male is reported as significant, although the CI is 0.99 - 1.57. Please be more careful when making tables and report results.

- Tables are enumerated incorrectly from Table 4 onwards.

Reviewer #2: The authors undertook a prospective study on factors associated with seroprevalence and seroconversion of DENV and CHIKV among children in Kenya. They attempted to identify the predictors of DENV and CHIKV seroprevalence and seroconversion and describe the temporal patterns of DENV and CHIKV seroconversion. However, the authors did not adequately describe the rationale, significance, and inclusion and exclusion criteria of the study. The statistical methods that were used in determining results, such as logistic regression and Kaplan-Meier analysis, were also not clearly described. It is therefore recommended that the authors revise the introduction and methods sections to fully elucidate their approach. Additionally, the study had minor grammatical issues. In addition, authors should consider modifying their manuscript title. Lastly, and most importantly, the authors should clearly demonstrate the novel findings of their study in the body of literature. This could be achieved by highlighting how their study adds to existing literature and identifying any new or significant findings.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Braulio Mark Valencia Arroyo

Reviewer #2: Yes: Tewelde Tesfaye Gebremariam

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012616.r003

Decision Letter 1

Andrea Marzi, Chaturaka Rodrigo

12 Aug 2024

Dear Dr. Tariq,

Thank you very much for submitting your manuscript "Understanding the factors contributing to dengue virus and chikungunya virus  seropositivity and seroconversion among children in Kenya" for consideration at PLOS Neglected Tropical Diseases. The revised version was reviewed by the same reviewers with one recommending acceptance while the other recommended rejection. Thus we had to secure a third review and that reviewer feels this version still needs significant revisions. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments. Your revised submission will only be sent back to the third reviewer as the other two had already submitted their final decision.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Chaturaka Rodrigo, MD PhD FRCP

Academic Editor

PLOS Neglected Tropical Diseases

Andrea Marzi

Section Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: Unfortunately, the authors did not adequately address the major issues raised, and I cannot see improvements in the manuscript.

Reviewer #3: The lines number are based on the pdf PNTD-D-23-01567_R1.

1. Lines 124-125: There is a lack of clarity in the methods section regarding the definitions and criteria for seropositivity and seroconversion for DENV.

a. Within this definition issue, should individuals who are already seropositive (IgG+ at baseline) be excluded from the follow-up when mapping seroconversion?

b. The same question (1a) applies to CHIKV cases.

2. Line 267: It is unclear whether the univariate analysis of variables against seropositivity accounted for data across the 5-year follow-up period. Since variables such as wealth index, population, and crowding index are not constant and likely change during the study period, how did the authors account for these changes in their analysis?

3. There is a repeated lack of clarity regarding the definitions and cutoffs for various variables. For instance, the definition of the "type" of water container is unclear, the cutoff for 10 km in line 293 is unclear, the crowding index definition is unclear, and the definition of "outdoor time" is unclear. Additionally, it is not clear which specific water containers were considered and their relevance to the study's aim. If the study's focus is on mosquito breeding, it should include information on how long containers need to be left unused to be optimal for breeding. What happens to a bucket that is used 5 times daily and kept open? Does this bucket increase mosquito breeding chances? The contextual information seems to be missing.

4. Line 238: It is suggested to refer to the method for the “mosquito index.” However, it is unclear where this index is defined in the methods section.

5. Line 190: It is written that the “crowding index was defined as the number of residents living in the household divided by the number of rooms in the house.” What happens if a household has larger rooms but fewer rooms overall? How do you account for density in such cases?

6. Line 203: The definition of “outdoor time” is missing. Since the study includes both housebound infants and school-going children, the latter will bias the outdoor time regardless, as infants have less mobility.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: 1. Table 1: Outdoor Time: Of the 322 individuals (9.3%) marked as having “No” outdoor time, what age group do they represent? Is this group primarily composed of infants?

2. Line 256: "DENV seroprevalence exhibited an increase from 2014-2017 with a decline in 2018." Can you please indicate which figure or table this statement is referring to?

3. Line 282: The author states, "…..decreased odds of DENV seropositivity" and relates this to protection in Abstract Line 43. Clarification is needed on the premise that the decrease in odds ratio (OR) for seropositivity is related to protection against DENV.

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: 1. Are the conclusions supported by the data presented?

Answer: The conclusions are not fully supported by the data presented. The reviewer has identified several areas where the methods and interpretations lack clarity or rigor, which undermines the confidence in the conclusions drawn from the study. Specific concerns include the definitions and criteria for seropositivity and seroconversion, the handling of changing variables over the study period, and the contextual relevance of certain variables.

2. Are the limitations of analysis clearly described?

Answer: The limitations of the analysis are not clearly described. The reviewer points out multiple methodological issues that need to be addressed, such as the unclear definitions of key variables, how changes in socio-economic factors were accounted for, and the lack of clarity in the analysis of the univariate and multivariate models. These limitations need to be explicitly stated and discussed in the study.

3. Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

Answer: The abstract does not sufficiently discuss how the data can advance understanding of the topic. While the study provides data on seropositivity and seroconversion rates and identifies some risk factors, the lack of methodological clarity and rigorous interpretation limits the extent to which these findings can be considered robust contributions to the field. The authors need to more clearly articulate how their findings contribute to existing knowledge and what implications they have for future research and public health interventions.

4. Is public health relevance addressed?

Answer: The public health relevance is partially addressed. The study aims to identify risk factors for DENV and CHIKV seropositivity and seroconversion, which has clear public health implications. However, due to the identified issues with the methods and interpretations, the practical applications and significance of the findings are not fully clear. The authors need to better highlight how their findings can inform public health strategies and interventions, especially in the context of vector control and disease prevention in endemic areas.

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: Dengue virus (DENV) and chikungunya virus (CHIKV) are significant causes of febrile illness among children in Kenya. This study investigates the relationships between various household, socio-economic, demographic, and behavioral risk factors and the seropositivity and seroconversion of DENV and CHIKV in four settlements in Kenya. A pediatric cohort of 3,445 children was followed prospectively from 2014 to 2018. Temporal patterns of seroconversion were described using Kaplan-Meier curves, and logistic regression with generalized linear mixed models identified potential exposure risk factors.

Reviewer Comments Summary

1. Definitions and Criteria (Lines 124-125):

- Clarification needed on definitions and criteria for seropositivity and seroconversion for DENV.

- Should seropositive individuals at baseline be excluded from follow-up when mapping seroconversion?

- The same question applies to CHIKV cases.

2. Univariate Analysis (Line 267):

- Unclear if univariate analysis accounted for data across the 5-year follow-up period.

- Variables such as wealth index, population, and crowding index likely changed during the study. How were these changes accounted for in the analysis?

3. Variable Definitions and Cutoffs:

- Repeated lack of clarity on definitions and cutoffs for various variables.

- Specific concerns about the "type" of water container, the cutoff for 10 km, the crowding index definition, and the definition of "outdoor time."

- Need clarification on the relevance of specific water containers to the study's aim, particularly regarding mosquito breeding.

4. Mosquito Index (Line 238):

- Reference to "mosquito index" is unclear in the methods section.

5. Crowding Index (Line 190):

- Definition provided but unclear how density is accounted for in households with larger rooms but fewer rooms overall.

6. Outdoor Time (Line 203):

- Missing definition of "outdoor time."

- Bias potential between housebound infants and school-going children, as infants have less mobility.

Specific Results Clarifications

1. Table 1: Outdoor Time:

- For the 322 individuals (9.3%) marked as having “No” outdoor time, what age group do they represent? Is this group primarily composed of infants?

2. Seroprevalence Trend (Line 256):

- "DENV seroprevalence exhibited an increase from 2014-2017 with a decline in 2018." Indicate which figure or table this statement refers to.

3. Decreased Odds of Seropositivity (Line 282):

- Clarification needed on how the decreased odds ratio (OR) for seropositivity relates to protection against DENV.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes: Anurag Adhikari

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012616.r005

Decision Letter 2

Andrea Marzi, Chaturaka Rodrigo

8 Oct 2024

Dear Dr. Tariq,

We are pleased to inform you that your manuscript 'Understanding the factors contributing to dengue virus and chikungunya virus  seropositivity and seroconversion among children in Kenya' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Chaturaka Rodrigo, MD PhD FRCP

Academic Editor

PLOS Neglected Tropical Diseases

Andrea Marzi

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #3: Yes, the methods has been substantially clarified and revised in this rebuttal.

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #3: Yes.

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #3: Yes.

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #3: Minor modification for uniformity: Please consider making the font and graphline width uniform accross survival probability plots in Figure 3 and 4 (i.e panel "a" looks as if its in bigger font and line graphline width than rest of "b-c-d").

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #3: No comments.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #3: Yes: Anurag Adhikari

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0012616.r006

Acceptance letter

Andrea Marzi, Chaturaka Rodrigo

4 Nov 2024

Dear Dr. Tariq,

We are delighted to inform you that your manuscript, "Understanding the factors contributing to dengue virus and chikungunya virus  seropositivity and seroconversion among children in Kenya," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Text. Supplementary File.

    (DOCX)

    pntd.0012616.s001.docx (19.9KB, docx)
    Attachment

    Submitted filename: Response_to_reviewers_may13_2024_at_AK_at_final.docx

    pntd.0012616.s002.docx (145.3KB, docx)
    Attachment

    Submitted filename: Response_to_Reviewer_sept13_2024_final.docx

    pntd.0012616.s003.docx (24.4KB, docx)

    Data Availability Statement

    The datasets generated and/or analyzed during the current study are available from the github repository: https://github.com/atariq2891/Kenya-CHIKV-and-DENV-data-2014-2018.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES